Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Bodrogi

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Anticancer Research|August 26, 1998
Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteinsH Eid, L Géczi, A Mágori, et al.
Cancer Chemotherapy and Pharmacology|January 25, 2008
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancerJ Horti, E Juhasz, Z Monostori, et al.
Acta Pharmaceutica Hungarica|January 1, 1978
[Study of Lycurim pharmacokinetics in man]J Csetényi, L Hegedüs, I Számel, et al.
Orvosi Hetilap|February 12, 1989
[Combined therapy of malignant testicular tumors]J Pintér, I Bodrogi, J G Pintér, et al.
Oncology|June 8, 2006
Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emissionK Biro, L Noszek, P Prekopp, et al.
Orvosi Hetilap|March 15, 1992
[K-cell activity in patients with germ cell testicular tumors. Effect of cytostatic therapy]R Kirschner, I Bodrogi, C Kulhavi, et al.
Orvosi Hetilap|October 3, 1998
[Bcl-2 expression in testicular cancer in relation to tumor progression]H Eid, M Gulyás, A Mágori, et al.
Anticancer Research|July 1, 1997
Is p53 expression, detected by immunohistochemistry, an important parameter of response to treatment in testis cancer?H Eid, M Van der Looij, E Institoris, et al.
International Urology and Nephrology|February 11, 2000
The effect of intravesical mitomycin C on the recurrence of superficial (Ta-T1) bladder cancer. A Hungarian Multicenter StudyJ Kondás, L Kiss, A Határ, et al.
Neoplasma|January 1, 1990
Vinblastine, cisplatin and bleomycin treatment of advanced nonseminomatous testicular tumorsI Bodrogi, M Baki, J Horti, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Anticancer Research|August 26, 1998
Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteinsH Eid, L Géczi, A Mágori, et al.
Cancer Chemotherapy and Pharmacology|January 25, 2008
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancerJ Horti, E Juhasz, Z Monostori, et al.
Acta Pharmaceutica Hungarica|January 1, 1978
[Study of Lycurim pharmacokinetics in man]J Csetényi, L Hegedüs, I Számel, et al.
Orvosi Hetilap|February 12, 1989
[Combined therapy of malignant testicular tumors]J Pintér, I Bodrogi, J G Pintér, et al.
Oncology|June 8, 2006
Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emissionK Biro, L Noszek, P Prekopp, et al.
Orvosi Hetilap|March 15, 1992
[K-cell activity in patients with germ cell testicular tumors. Effect of cytostatic therapy]R Kirschner, I Bodrogi, C Kulhavi, et al.
Orvosi Hetilap|October 3, 1998
[Bcl-2 expression in testicular cancer in relation to tumor progression]H Eid, M Gulyás, A Mágori, et al.
Anticancer Research|July 1, 1997
Is p53 expression, detected by immunohistochemistry, an important parameter of response to treatment in testis cancer?H Eid, M Van der Looij, E Institoris, et al.
International Urology and Nephrology|February 11, 2000
The effect of intravesical mitomycin C on the recurrence of superficial (Ta-T1) bladder cancer. A Hungarian Multicenter StudyJ Kondás, L Kiss, A Határ, et al.
Neoplasma|January 1, 1990
Vinblastine, cisplatin and bleomycin treatment of advanced nonseminomatous testicular tumorsI Bodrogi, M Baki, J Horti, et al.
Pageof 7